Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Esophageal CancerGastric Cancer
Interventions
DRUG

Cetuximab,Paclitaxel, Carboplatin

IV treatment for 6 weeks

Trial Locations (1)

02912

Brown University Oncology Group, Providence

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Brown University

OTHER